385 related articles for article (PubMed ID: 22089400)
1. Primary spinal natural killer/T-cell lymphoma successfully treated with concurrent chemoradiotherapy and autologous stem cell transplantation.
Kim KT; Kim YB; Kim HJ; Cha YJ; Lee SJ; Park E
Spine (Phila Pa 1976); 2012 May; 37(10):E629-32. PubMed ID: 22089400
[TBL] [Abstract][Full Text] [Related]
2. Natural killer/T-cell nasal-type lymphoma: unusual primary spinal tumor.
Yang C; Ma J; Yang X; Jia L; Liu H; Xiao J
Spine (Phila Pa 1976); 2008 Nov; 33(24):E929-32. PubMed ID: 19011534
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
5. Extranodal natural killer/T-cell lymphoma, nasal-type.
Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
[TBL] [Abstract][Full Text] [Related]
6. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
8. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
10. First report of primary pancreatic natural killer/T-cell nasal type lymphoma.
Liu W; Hua R; Zhang JF; Huo YM; Liu DJ; Sun YW
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):318-22. PubMed ID: 23426534
[TBL] [Abstract][Full Text] [Related]
11. [Sinonasal extranodal natural killer/T-cell lymphoma: a case report and review of recent developments in the management].
Dağoğlu RN; Ozdemir O; Ergen A; Ağaoğlu FY
Kulak Burun Bogaz Ihtis Derg; 2012; 22(3):164-71. PubMed ID: 22663927
[TBL] [Abstract][Full Text] [Related]
12. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Chang BH; Stork L; Fan G
Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
[TBL] [Abstract][Full Text] [Related]
13. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
[TBL] [Abstract][Full Text] [Related]
16. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
17. Nasal NK/T-cell lymphoma in the paediatric population. Two case reports.
Zeglaoui I; Belcadhi M; Sriha B; Bouzouita K
B-ENT; 2009; 5(2):119-23. PubMed ID: 19670600
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
20. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.
Koizumi K; Fujimoto K; Haseyama Y; Endo T; Nishio M; Yokota K; Itoh T; Sawada K; Koike T
Eur J Haematol; 2004 Feb; 72(2):140-4. PubMed ID: 14962252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
